Pearman J W, Kosaras F P, Harper W E
Med J Aust. 1978 Apr 22;1(8):452-4. doi: 10.5694/j.1326-5377.1978.tb141939.x.
The in-vitro activity of ticarcillin was found to be greater than that of carbenicillin against 97 out of 100 strains of Pseudomonas aeruginosa which were recently isolated from clinical specimens at the Royal Perth Hospital complex. These results indicate that ticarcillin should be considered for use in place of carbenicillin for treating infections caused by P. aeruginosa.
在皇家珀斯医院综合院区最近从临床标本中分离出的100株铜绿假单胞菌中,发现替卡西林对其中97株的体外活性大于羧苄西林。这些结果表明,在治疗由铜绿假单胞菌引起的感染时,应考虑使用替卡西林替代羧苄西林。